Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Colorectal Cancer Risk Reduction
NCT01312467Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of metformin in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Mar 2011; status: completed.
02
Drugs
metformin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01312467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312467.